GlaxoSmithKline PLC (GSK.L)
25 Jul 2014
|Market Cap (Mil.):||£69,000.20|
|Shares Outstanding (Mil.):||4,848.92|
LONDON, July 25 - British lenders who focus on the domestic market outperformed a slightly negative FTSE 100 index on Friday after strong results from Royal Bank of Scotland and solid economic growth data.
LONDON, July 25 - British lenders who focus on the domestic market outpaced a flat FTSE 100 index on Friday after strong results from Royal Bank of Scotland and solid economic output data.
LONDON - GlaxoSmithKline faces new allegations of corruption, this time in Syria, where the drugmaker and its distributor have been accused of paying bribes to secure business, according to a whistleblower's email reviewed by Reuters.
LONDON - GlaxoSmithKline said on Thursday it is applying for regulatory approval for the world's first vaccine against malaria, designed for children in Africa.
* Mosquito-borne malaria kills over 600,000 people a year
TEL AVIV - Israel-based Atox Bio, a developer of therapeutics for severe infections, said on Thursday it has raised $23 million in an investment round led by SR One, the healthcare venture capital fund of GlaxoSmithKline.
* Gsk announces eu regulatory submission for malaria vaccine candidate rts,s
TEL AVIV, July 24 - Israel-based Atox Bio, a developer of therapeutics for severe infections, said on Thursday it has raised $23 million in an investment round led by SR One, the healthcare venture capital fund of GlaxoSmithKline .
LONDON, July 24 - GlaxoSmithKline is applying for regulatory approval for the world's first vaccine against malaria, designed for use in children in Africa.
(The author is a Reuters Breakingviews columnist. The opinions expressed are his own.)
Earnings vs. Estimates
Analyst Research Reports
Provider: Pechala's Reports
GlaxoSmithKline PLC: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.
Provider: Reuters Investment Profile
Provider: Thomson Reuters Stock Report
Provider: Ford Investor Services, Inc.
Jefferson Research Financial Sonar Report. A detailed analysis of the current fundamental performance of GLAXOSMITHKLINE PLC -ADR including Earnings Quality, Cash Flow Quality, Operating Efficiency, Balance Sheet Quality and Valuation.
Provider: Jefferson Research
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.